Your browser doesn't support javascript.
loading
Author Correction: BCAT1 restricts αKG levels in AML stem cells leading to IDHmut-like DNA hypermethylation.
Raffel, Simon; Falcone, Mattia; Kneisel, Niclas; Hansson, Jenny; Wang, Wei; Lutz, Christoph; Bullinger, Lars; Poschet, Gernot; Nonnenmacher, Yannic; Barnert, Andrea; Bahr, Carsten; Zeisberger, Petra; Przybylla, Adriana; Sohn, Markus; Tönjes, Martje; Erez, Ayelet; Adler, Lital; Jensen, Patrizia; Scholl, Claudia; Fröhling, Stefan; Cocciardi, Sibylle; Wuchter, Patrick; Thiede, Christian; Flörcken, Anne; Westermann, Jörg; Ehninger, Gerhard; Lichter, Peter; Hiller, Karsten; Hell, Rüdiger; Herrmann, Carl; Ho, Anthony D; Krijgsveld, Jeroen; Radlwimmer, Bernhard; Trumpp, Andreas.
Afiliação
  • Raffel S; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), 69120, Heidelberg, Germany.
  • Falcone M; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, 69120, Heidelberg, Germany.
  • Kneisel N; Department of Internal Medicine V, Heidelberg University Hospital, 69120, Heidelberg, Germany.
  • Hansson J; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), 69120, Heidelberg, Germany.
  • Wang W; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, 69120, Heidelberg, Germany.
  • Lutz C; Division of Molecular Genetics, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.
  • Bullinger L; Genome Biology Unit, European Molecular Biology Laboratory (EMBL), 69117, Heidelberg, Germany.
  • Poschet G; Division of Molecular Genetics, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.
  • Nonnenmacher Y; Department of Internal Medicine V, Heidelberg University Hospital, 69120, Heidelberg, Germany.
  • Barnert A; Department of Internal Medicine III, University Hospital Ulm, 89081, Ulm, Germany.
  • Bahr C; Centre for Organismal Studies (COS), University of Heidelberg, 69120, Heidelberg, Germany.
  • Zeisberger P; Department of Bioinfomatics and Biochemistry and Braunschweig Integrated Center of Systems Biology (BRICS), Technical University Braunschweig, 38106, Braunschweig, Germany.
  • Przybylla A; Luxemburg Centre for Systems Biomedicine, University of Luxemburg, L-4367, Belvaux, Luxembourg.
  • Sohn M; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), 69120, Heidelberg, Germany.
  • Tönjes M; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, 69120, Heidelberg, Germany.
  • Erez A; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), 69120, Heidelberg, Germany.
  • Adler L; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, 69120, Heidelberg, Germany.
  • Jensen P; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), 69120, Heidelberg, Germany.
  • Scholl C; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, 69120, Heidelberg, Germany.
  • Fröhling S; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), 69120, Heidelberg, Germany.
  • Cocciardi S; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, 69120, Heidelberg, Germany.
  • Wuchter P; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), 69120, Heidelberg, Germany.
  • Thiede C; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, 69120, Heidelberg, Germany.
  • Flörcken A; Division of Molecular Genetics, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.
  • Westermann J; Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel.
  • Ehninger G; Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel.
  • Lichter P; Department of Translational Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.
  • Hiller K; Division of Applied Functional Genomics, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.
  • Hell R; German Cancer Consortium (DKTK), DKFZ, 69120, Heidelberg, Germany.
  • Herrmann C; Department of Translational Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.
  • Ho AD; Section for Personalized Oncology, Heidelberg University Hospital, 69120, Heidelberg, Germany.
  • Krijgsveld J; German Cancer Consortium (DKTK), DKFZ, 69120, Heidelberg, Germany.
  • Radlwimmer B; Department of Internal Medicine III, University Hospital Ulm, 89081, Ulm, Germany.
  • Trumpp A; Department of Internal Medicine V, Heidelberg University Hospital, 69120, Heidelberg, Germany.
Nature ; 560(7718): E28, 2018 08.
Article em En | MEDLINE | ID: mdl-30069041
In Extended Data Fig. 1a of this Letter, the flow cytometry plot depicting the surface phenotype of AML sample DD08 was a duplicate of the plot for AML sample DD06. Supplementary Data 4 has been added to the Supplementary Information of the original Letter to clarify the proteome data acquisition and presentation. The original Letter has been corrected online.
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Nature Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Nature Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Alemanha